Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model

Assaf Lask, MSc, Eran Ophir, MSc, Noga Or-Geva, BSc, Adva Cohen, MSc, Ran Afik, MSc, Yaki Eidelstein, MSc, Robert Negrin, MD, Arnon Nagler, M.D., Alain Berrebi, MD, David Hagin, MD, Yair Reisner, PhD

Blood (2010) 116 (21): 424.

https://doi.org/10.1182/blood.V116.21.424.424

Published: 2010

Journal Articles

Evaluation of Novel S-Allyl Derivatives of 6-Mercapto-Purine against B-CLL: Combining the Effects of Different Compounds in A Single Molecule.

Fabian David Arditti, PhD, Mordechai Shtalrid, MD, Lucette Bassous, Lev Shvidel, MD, Alain Berrebi, MD, Talia Miron, PhD

Blood (2009) 114 (22): 3437.

https://doi.org/10.1182/blood.V114.22.3437.3437

Published: 2009

Journal Articles

The Significance of Elevated Beta 2-Microglobulin (b2-m) in B-CLL: Evidence of in Vitro b2-m Secretion Following Activation of B-CLL Cells.

Alain Berrebi, MD, Lev Shvidel, MD, Fabian David Arditti, PhD, Lucette Bassous, Michal Haran, Mordechai Shtalrid, MD

Blood (2009) 114 (22): 4380.

https://doi.org/10.1182/blood.V114.22.4380.4380

Published: 2009

Journal Articles

First-Line Treatment with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Improves Overall Survival (OS) in Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Randomized Phase III Trial On Behalf of An International Group of Investigators and the German CLL Study Group.

Blood (2009) 114 (22): 535.

https://doi.org/10.1182/blood.V114.22.535.535

Published: 2009

Journal Articles

Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine and Cyclophosphamide (FC) Improves Response Rates and Progression-Free Survival (PFS) of Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL)

Blood (2008) 112 (11): 325.

https://doi.org/10.1182/blood.V112.11.325.325

Published: 2008

Journal Articles

Predictive Factors to Hypogammaglobulinemia and Non-Neutropenic Infection Complications after Rituximab/Chemotherapy Treatment

Kalman Filanovsky, MD, Lev Shvidel, MD, Mordechai Shtalrid, MD, Michal Haran, MD, Adrian Duek, MD, Alain Berrebi

Blood (2007) 110 (11): 1288.

https://doi.org/10.1182/blood.V110.11.1288.1288

Published: 2007

Journal Articles

Eradication of B Cell Malignancies by Anti-3 rd Party CTLs: A Novel Role for MHC Class I.

Assaf Lask, MSc, Polina Goichberg, PhD, Rinat Goren-Arbel, PhD, Oren Milstein, MSc, Shraga Aviner, MD, Ilan Feine, Tirza Klein, PhD, Alain Berrebi, MD, Yair Reisner, PhD

Blood (2007) 110 (11): 2759.

https://doi.org/10.1182/blood.V110.11.2759.2759

Published: 2007

Journal Articles

Chromosomal Abnormalities Detected by FISH in CLL May Be Influenced by Ethnic Origin: Preliminary Data from a Multicenter Study in Israel for the Israel CLL Study Group (ICLLSG).

Rosa Ruchlemer, MD, Lev Shvidel, MD, Andre A. Baester, MD, Osnat Bairey, MD, Alain Berrebi, MD, Aaron Polliack, MD

Blood (2007) 110 (11): 4705.

https://doi.org/10.1182/blood.V110.11.4705.4705

Published: 2007

Journal Articles

A Non-Invasive Evaluation of Hemoglobin with a New Optical Sensor.

Alain Berrebi, MD, Orna Amir, PhD, Aharon Weinstein, MSc, Emmanuel Monashkin, MD, PhD, Paul Holland, MD

Blood (2006) 108 (11): 1302.

https://doi.org/10.1182/blood.V108.11.1302.1302

Published: 2006

Journal Articles

CD74 Is a Novel Survival Receptor in Chronic Lymphocytic Leukemia.

Inbal Binsky, BSc, Michal Haran, MD, Diana Starlets, BSC, Nurit Harpaz, Lev Shvidel, M.D., Alain Berrebi, MD, Idit Shachar, PhD

Blood (2006) 108 (11): 2812.

https://doi.org/10.1182/blood.V108.11.2812.2812

Published: 2006

Journal Articles

Methyl Jasmonate: A New Treatment for B-CLL?.

Alain Berrebi, MD, Lucette Bassous, Rinat Borenshtain, PhD, Eliezer Flescher, PhD

Blood (2006) 108 (11): 4984.

https://doi.org/10.1182/blood.V108.11.4984.4984

Published: 2006

Journal Articles

Is Thalidomide the Sole Treatment of Primary Myelofibrosis? Report of a Case with Complete Reversal of Bone Marrow Fibrosis and Splenomegaly.

Alain Berrebi, MD, Lev Shvidel, MD, Irena Shpivak, MD, Edit Feldberg, MD

Blood (2006) 108 (11): 4905.

https://doi.org/10.1182/blood.V108.11.4905.4905

Published: 2006

Journal Articles

The Jak2-Inhibitor AG409 Affects Survival of BFU-E and CFU-GM of Myeloproliferative Disorder Cells Carrying the JAK2 V617F Mutation.

Adrian Duek, MD, Ina Lichman, MD, Mordejai Shtalrid, MD, Alain Berrebi

Blood (2006) 108 (11): 4907.

https://doi.org/10.1182/blood.V108.11.4907.4907

Published: 2006

Journal Articles

Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival

Diana Starlets, Yael Gore, Inbal Binsky, Michal Haran, Nurit Harpaz, Lev Shvidel, Shirly Becker-Herman, Alain Berrebi, Idit Shachar

Blood (2006) 107 (12): 4807–4816.

https://doi.org/10.1182/blood-2005-11-4334

Published: 2006

Journal Articles

Down-Regulation of Activin A by Lymphoma: A Possible Mechanism of Bone Marrow Involvement.

Michal Z. Haran, MD, Reshmi Parameswaran, Edit Feldberg, MD, Mina Fogel, PhD, Monica Huszar, MD, Alain Berrebi, MD, Mordechai Shtalrid, MD, Lev Shvidel, MD, Adrian Duek, MD, Merav Leiba, PhD, Arnon Nagler, MD, Dov Zipori, PhD

Blood (2005) 106 (11): 4669.

https://doi.org/10.1182/blood.V106.11.4669.4669

Published: 2005

Journal Articles

High Risk Pregnancies in Women with Diamond Blackfan Anaemia: A Survey of 64 Pregnancies from the French and German Registries.

Thierry Leblanc, MD, Laurence Faivre, MD, Jorg Meerpohl, MD, Lydie Da Costa, MD, PhD, Christian Nouvel, MD, Francis Bauters, MD, Bertrand Coiffier, MD, Pierre-Yves Peaud, MD, Patrick Rispal, MD, Alain Berrebi, MD, Claire Berger, MD, Bruno Varet, MD, Charlotte Niemeyer, MD, PhD, Gil Tchernia, MD

Blood (2005) 106 (11): 3549.

https://doi.org/10.1182/blood.V106.11.3549.3549

Published: 2005

Journal Articles

Epidemiology and Features of Multiple Myeloma in a Cohort of 110 Patients from a Central Area of Israel.

Adrian Duek, MD, Michal Haran, MD, Lev Shvidel, MD, Mordechai Shtalrid, M.D, Erica Sigler, MD, Alain Berrebi, M.D.

Blood (2005) 106 (11): 5169.

https://doi.org/10.1182/blood.V106.11.5169.5169

Published: 2005

Journal Articles

Evaluation of a Non-Invasive Hematocrit Determination Device.

Alain Berrebi, MD, Orna Amir, PhD, Aharon Weinstein, MSc, Olga Herzenstein, MSc, David Dvir, MD, Emanuel Monashkin, MD, Efi Gabis, BSc, Paul Holland, MD

Blood (2005) 106 (11): 4176.

https://doi.org/10.1182/blood.V106.11.4176.4176

Published: 2005

Journal Articles

Eradication of B-CLL by autologous and allogeneic host nonreactive anti–third-party CTLs

Fabian D. Arditti, Shraga Aviner, Benjamin Dekel, Rita Krauthgamer, Judith Gan, Arnon Nagler, Antonio Tabilio, Massimo Martelli, Alain Berrebi, Yair Reisner

Blood (2005) 105 (8): 3365–3371.

https://doi.org/10.1182/blood-2003-03-0982

Published: 2005

Journal Articles

Immune regulatory activity of CD34 + progenitor cells: evidence for a deletion-based mechanism mediated by TNF-α

Hilit Gur, Rita Krauthgamer, Esther Bachar-Lustig, Helena Katchman, Rinat Arbel-Goren, Alain Berrebi, Tirza Klein, Arnon Nagler, Antonio Tabilio, Massimo F. Martelli, Yair Reisner

Blood (2005) 105 (6): 2585–2593.

https://doi.org/10.1182/blood-2002-11-3463

Published: 2005

NARROW

Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model

Evaluation of Novel S-Allyl Derivatives of 6-Mercapto-Purine against B-CLL: Combining the Effects of Different Compounds in A Single Molecule.

The Significance of Elevated Beta 2-Microglobulin (b2-m) in B-CLL: Evidence of in Vitro b2-m Secretion Following Activation of B-CLL Cells.

Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine and Cyclophosphamide (FC) Improves Response Rates and Progression-Free Survival (PFS) of Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL)

Predictive Factors to Hypogammaglobulinemia and Non-Neutropenic Infection Complications after Rituximab/Chemotherapy Treatment

Eradication of B Cell Malignancies by Anti-3 rd Party CTLs: A Novel Role for MHC Class I.

Chromosomal Abnormalities Detected by FISH in CLL May Be Influenced by Ethnic Origin: Preliminary Data from a Multicenter Study in Israel for the Israel CLL Study Group (ICLLSG).

A Non-Invasive Evaluation of Hemoglobin with a New Optical Sensor.

CD74 Is a Novel Survival Receptor in Chronic Lymphocytic Leukemia.

Methyl Jasmonate: A New Treatment for B-CLL?.

Is Thalidomide the Sole Treatment of Primary Myelofibrosis? Report of a Case with Complete Reversal of Bone Marrow Fibrosis and Splenomegaly.

The Jak2-Inhibitor AG409 Affects Survival of BFU-E and CFU-GM of Myeloproliferative Disorder Cells Carrying the JAK2 V617F Mutation.

Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival

Down-Regulation of Activin A by Lymphoma: A Possible Mechanism of Bone Marrow Involvement.

High Risk Pregnancies in Women with Diamond Blackfan Anaemia: A Survey of 64 Pregnancies from the French and German Registries.

Epidemiology and Features of Multiple Myeloma in a Cohort of 110 Patients from a Central Area of Israel.

Evaluation of a Non-Invasive Hematocrit Determination Device.

Eradication of B-CLL by autologous and allogeneic host nonreactive anti–third-party CTLs

Immune regulatory activity of CD34 + progenitor cells: evidence for a deletion-based mechanism mediated by TNF-α

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only